Dianthus Therapeutics, Inc. (DNTH) Financials

DNTH Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 1.2 billion 45.6 million
Dec. 31, 2025 530.9 million 37.5 million
Sept. 30, 2025 577.4 million 31.0 million
June 30, 2025 326.1 million 23.0 million

DNTH Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -28.9 million 10.6 million
Dec. 31, 2025 -47.1 million 6.0 million
Sept. 30, 2025 -30.6 million 5.8 million
June 30, 2025 -23.9 million 5.7 million

DNTH Net Income

No data available :(

DNTH Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 1.1 billion 965000 -
Dec. 31, 2025 404.3 million 1.0 million 1.4 million
Sept. 30, 2025 402.6 million 1.1 million 1.3 million
June 30, 2025 257.4 million - 1.3 million

DNTH Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 48.0 million
Dec. 31, 2025 37.8 million
Sept. 30, 2025 37.8 million
June 30, 2025 35.8 million

DNTH Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 10000 34.5 million 12.5 million -
Dec. 31, 2025 138000 59.9 million 9.9 million -
Sept. 30, 2025 5000 32.5 million 8.2 million -
June 30, 2025 46000 26.3 million 8.9 million -

DNTH Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 463000 76000
Dec. 31, 2025 284000 -
Sept. 30, 2025 396000 99000
June 30, 2025 193000 99000

DNTH Revenue by Segment
Graph available only for paid members. Upgrade to see it.

DNTH

Price: $82.51

52 week price:
16.64
96.50

Earnings Per Share: -4.23 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 3.5 billion

Links: